Asia Green Biotechnology Corp. (TSE:ASIA) has released an update.
Asia Green Biotechnology Corp. has recently filed its annual financial documents and management discussion analysis for the year ended December 31, 2023, on SEDAR, following a series of news releases. The company anticipates the removal of the Management Cease Trade Order placed by the Alberta Securities Commission. Furthermore, Vincent Ghazar has stepped down as CFO and Director, but will stay on as a consultant.
For further insights into TSE:ASIA stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
